Jessica K R Boult Selected Research

Jessica K R Boult Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 09/2010
6	Hypoxia (Hypoxemia) 04/2018 - 10/2012
4	Glioma (Gliomas) 11/2018 - 10/2012
3	Breast Neoplasms (Breast Cancer) 06/2023 - 09/2017
3	Necrosis 04/2018 - 03/2012
2	Neuroblastoma 01/2020 - 01/2013
2	Carcinoma (Carcinomatosis) 10/2018 - 04/2018
2	Prostatic Neoplasms (Prostate Cancer) 10/2018 - 10/2016
2	Fibrosis (Cirrhosis) 04/2018 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 09/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 01/2017
2	Brain Neoplasms (Brain Tumor) 01/2018 - 09/2017
2	Prolactinoma (Prolactinomas) 09/2013 - 08/2013
1	Neoplasm Metastasis (Metastasis) 06/2023
1	Diffuse Intrinsic Pontine Glioma 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Contracture 01/2018
1	Cysts 01/2018
1	Hyperoxia 01/2018
1	Adenocarcinoma 11/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Drug-Related Side Effects and Adverse Reactions 09/2015
1	Medulloblastoma 01/2015
1	Vascular Remodeling 10/2012
1	Colorectal Neoplasms (Colorectal Cancer) 07/2011

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2011
6	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2017 - 09/2010
5	carbogenIBA 10/2016 - 07/2011
4	pimonidazoleIBA 04/2018 - 10/2012
4	Oxygen (Dioxygen)IBA 01/2018 - 08/2013
4	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2018 - 07/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 10/2012
3	CollagenIBA 11/2019 - 04/2015
3	cediranib (AZD2171)IBA 09/2017 - 10/2012
3	N-acetylcochinol-O-phosphateIBA 09/2015 - 03/2012
2	Gadolinium DTPA (Magnevist)FDA Link 01/2018 - 11/2016
1	Hyaluronic Acid (Hyaluronan)IBA 06/2023
1	dipinacoline glutamateIBA 01/2022
1	vistusertibIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Aurora Kinase AIBA 01/2020
1	MLN 8237IBA 01/2020
1	Collagenases (Collagenase)FDA Link 11/2019
1	Doxycycline (Periostat)FDA LinkGeneric 11/2018
1	ElementsIBA 11/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2018
1	MK 2206IBA 10/2018
1	Choline (Choline Chloride)IBA 10/2018
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 04/2018
1	C.I. direct red 80IBA 04/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Contrast MediaIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Evans Blue (Blue, Evans)FDA Link 09/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	Hydralazine (Apresoline)FDA LinkGeneric 02/2016
1	vanucizumabIBA 01/2016
1	Omalizumab (Xolair)FDA Link 01/2016
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Immunoglobulin E (IgE)IBA 01/2016
1	azomycinIBA 09/2013
1	CCI 103FIBA 09/2013
1	Hemoglobins (Hemoglobin)IBA 08/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Angiogenesis InhibitorsIBA 01/2013
1	tandutinibIBA 01/2013
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2013
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2012

Therapy/Procedure

14	Therapeutics 01/2022 - 10/2012
3	Aftercare (After-Treatment) 01/2016 - 10/2012
2	Intravenous Administration 10/2016 - 07/2011
1	Precision Medicine 01/2020
1	Mastectomy (Mammectomy) 01/2018
1	Radiotherapy 01/2018
1	Mammaplasty (Breast Reconstruction) 01/2018
1	Free Tissue Flaps 01/2018